Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study.

Prostate Int · 2020 · PMC7125379 · PMID 32257976

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

nearing significanceP = 0.051so close (0.05 < p ≤ 0.1)

However, the difference in PSA velocity in patients who received EBR was nearing significance ( P = 0.051), Table 6 .

also in 225 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.